Arkema (OTCMKTS:ARKAY – Get Free Report) posted its quarterly earnings data on Thursday. The basic materials company reported $1.40 earnings per share for the quarter, missing the consensus estimate of $1.49 by ($0.09), Zacks reports. Arkema had a return on equity of 4.30% and a net margin of 0.67%.
Arkema Price Performance
OTCMKTS ARKAY traded up $1.36 on Thursday, reaching $66.06. 887 shares of the stock traded hands, compared to its average volume of 1,887. Arkema has a 12 month low of $56.28 and a 12 month high of $79.36. The company has a market cap of $5.02 billion, a price-to-earnings ratio of 13.82 and a beta of 0.87. The firm’s fifty day simple moving average is $64.29 and its 200 day simple moving average is $66.92. The company has a quick ratio of 1.08, a current ratio of 1.52 and a debt-to-equity ratio of 0.42.
Analysts Set New Price Targets
Separately, Barclays upgraded shares of Arkema from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 12th. Six research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.
Check Out Our Latest Report on Arkema
About Arkema
Arkema is a France-based global specialty materials company that develops and manufactures products used in a wide range of industrial and consumer applications. Its portfolio includes specialty adhesives, high-performance polymers, acrylic materials, coating resins, additives and other chemical solutions designed to improve durability, performance and sustainability.
The company operates through businesses focused on Adhesive Solutions, Advanced Materials and Coating Solutions. Its products serve markets such as construction, automotive, electronics, packaging, renewable energy, consumer goods and industrial manufacturing.
Read More
- Five stocks we like better than Arkema
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
